Publication | Closed Access

Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention

Percutaneous Coronary InterventionHealth PolicyCardiovascular DiseaseAtherosclerosisCoronary Plaque RegressionDual Lipid-lowering StrategyDyslipidemiaPreventive CardiologyAcute Myocardial InfarctionPublic HealthMedicineCardiologyEpidemiologyCoronary Artery DiseaseCoronary Heart Disease